---
title: "Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287638323.md"
description: "Tempus AI, Inc. (NASDAQ: TEM), a technology firm at the forefront of using AI to enhance precision medicine, revealed that 37 abstracts will be showcased at the 2026 American Society of Clinical Oncology (ASCO®) Annual Meeting in Chicago, Illinois from May 29 to June 3, 2026. This strong presence signifies a notable achievement for Tempus, with this year's meeting featuring the largest number of accepted research presentations in the company's history."
datetime: "2026-05-26T12:37:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287638323.md)
  - [en](https://longbridge.com/en/news/287638323.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287638323.md)
---

# Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Tempus AI, Inc. (NASDAQ: TEM), a technology firm at the forefront of using AI to enhance precision medicine, revealed that 37 abstracts will be showcased at the 2026 American Society of Clinical Oncology (ASCO®) Annual Meeting in Chicago, Illinois from May 29 to June 3, 2026. This strong presence signifies a notable achievement for Tempus, with this year's meeting featuring the largest number of accepted research presentations in the company's history.

### Related Stocks

- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)

## Related News & Research

- [Tempus AI Expands Smart Physician Platform With Generative AI Tools](https://longbridge.com/en/news/287786268.md)
- [Why Is Tempus AI Stock Surging On Thursday?](https://longbridge.com/en/news/287958467.md)
- [ImmunityBio Presents New Clinical and Comparative Data Across Lung and Bladder Cancer at ASCO 2026 | IBRX Stock News](https://longbridge.com/en/news/288311834.md)
- [Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows | TEM Stock News](https://longbridge.com/en/news/287772451.md)
- [BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026 | ONC Stock News](https://longbridge.com/en/news/287821090.md)